Table 1. Baseline Characteristics of 96 Hospitalized New TB Patients by HIV status in Kampala, Uganda.
| Factor | Level | HIV uninfected (n = 32) | HIV infected (n = 64) |
| – n (%) (unless specified) – | |||
| Age (years) | Mean (SD) | 32.3 (13.8) | 33.1 (8.2) |
| Sex | Female | 7 (22%) | 39 (61%) |
| Male | 25 (78%) | 25 (39%) | |
| BMI (kg/m2) | Mean (SD) | 16.6 (3.1) | 17.5 (3.5) |
| Karnofsky score | 70+ | 20 (62.5%) | 36 (56%) |
| ≤60 | 12 (37.5%) | 28 (44%) | |
| Duration of TB symptoms (weeks) | Median (IQR) | 16 (8 – 24) | 12 (8 – 16) |
| Drug resistance status at baseline | Sensitive to INH and RIF | 29 (91%) | 60 (94%) |
| Resistance to INH or RIF | 2 (6%) | 4 (6%) | |
| MDR | 1 (3%) | 0 | |
| Extent of disease on chest radiograph | Normal | 0 | 7 (11%) |
| Minimal | 0 | 14 (22%) | |
| Moderate | 3 (10%) | 15 (24%) | |
| Severe | 28 (90%) | 27 (43%) | |
| Cavitation | Absent | 4 (13%) | 49 (80%) |
| Present | 27 (87%) | 12 (20%) | |
| Miliary infiltrate | Absent | 30 (97%) | 58 (92%) |
| Present | 1 (3%) | 5 (8%) | |
| Sputum AFB smear microscopy grade | 1+ | 3 (9%) | 4 (6%) |
| 2+ | 3 (9%) | 14 (22%) | |
| 3+ | 5 (16%) | 11 (17%) | |
| 4+ | 21 (66%) | 35 (55%) | |
| BACTEC days-to-positive culture | ≥7 days | 14 (44%) | 32 (50%) |
| <7 days | 18 (56%) | 32 (50%) | |
| CD4 cell count (cells/µL) | Median (IQR) | - | 58 (18 – 106) |
| Symptoms (multiple responses allowed) | Fever | 20 (62%) | 51 (80%) |
| Rigors | 9 (28%) | 7 (11%) | |
| Night sweats | 21 (66%) | 46 (72%) | |
| Cough | 32 (100%) | 63 (98%) | |
| Produce sputum | 32 (100%) | 62 (97%) | |
| Purulent sputum | 18 (56%) | 29 (45%) | |
| Hemoptysis | 5 (16%) | 2 (3%) | |
| Dyspnea | 21 (66%) | 52 (81%) | |
| Chest Pain | 22 (69%) | 46 (72%) | |
| Loss of appetite | 21 (66%) | 53 (83%) | |
| Diarrhoea | 2 (6%) | 3 (5%) | |
| Weight Loss | 26 (81%) | 60 (94%) | |
| Swollen Glands | 0 | 12 (19%) | |
| Malaise | 23 (72%) | 52 (81%) | |
| Reason for hospitalization | Low Karnofsky score | 15 (47%) | 46 (72%) |
| Diagnostic evaluation | 8 (25%) | 9 (14%) | |
| Concurrent Illness | 2 (6%) | 10 (16%) | |
| Haemoptysis | 3 (9%) | 0 | |
| Social support | 2 (6%) | 0 | |
| Drug side effects | 0 | 0 | |
| Two reasons for admission | 3 (9%) | 2 (3%) | |
| Other reasons | 5 (16%) | 1 (2%) | |